SLC5A2 and Hyperglycemia: SGLT2 inhibitors improve hyperglycemia, reduce body weight and visceral adiposity, and improve various metabolic abnormalities associated with metabolic syndrome such as blood pressure, lipid profile, and serum uric acid level [3].